Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in MDCX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Interchange Capital Partners, LLC | 1.7M | $6.2M | +4.7% | 7.540% | 1.95% |
| 2 | Private Advisor Group, LLC | 240K | $110K | +36.8% | 1.089% | 0.00% |
| 3 | BRYN MAWR TRUST Co | 51K | $24K | 0.0% | 0.232% | 0.00% |
| 4 | May Hill Capital, LLC | 51K | $23K | +42.1% | 0.230% | 0.01% |
| 5 | COMMONWEALTH EQUITY SERVICES, LLC | 48K | $22K | +69.0% | 0.218% | 0.00% |
| 6 | UBS Group AG | 40K | $19K | +205.7% | 0.183% | 0.00% |
| 7 | BlackRock, Inc. | 37K | $17K | +8.7% | 0.169% | 0.00% |
| 8 | CITADEL ADVISORS LLC | 18K | $8K | — | 0.081% | 0.00% |
| 9 | TWO SIGMA SECURITIES, LLC | 16K | $7K | — | 0.071% | 0.00% |
| 10 | LPL Financial LLC | 16K | $7K | — | 0.071% | 0.00% |
| 11 | MARATHON CAPITAL MANAGEMENT | 16K | $7K | — | 0.070% | 0.00% |
| 12 | INTL FCSTONE INC. | 15K | $7K | — | 0.069% | 0.00% |
| 13 | BRAVE ASSET MANAGEMENT INC | 10K | $5K | -50.0% | 0.045% | 0.00% |
| 14 | ADVISOR GROUP HOLDINGS, INC. | 9K | $4K | 0.0% | 0.039% | 0.00% |
| 15 | MORGAN STANLEY | 5K | $3K | -70.1% | 0.025% | 0.00% |
| 16 | JONES FINANCIAL COMPANIES LLLP | 400 | $180 | 0.0% | 0.002% | 0.00% |
| 17 | Tower Research Capital LLC (TRC) | 121 | $56 | — | 0.001% | 0.00% |
| 18 | Virtu Financial LLC | 74K | $34 | — | 0.336% | 0.00% |
| 19 | WELLS FARGO & COMPANY/MN | 75 | $34 | 0.0% | 0.000% | 0.00% |
| 20 | SMITHFIELD TRUST CO | 11K | $5 | -17.3% | 0.052% | 0.00% |
| 21 | HAZLETT, BURT & WATSON, INC. | 425 | $0 | 0.0% | 0.002% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in MDCX — a direct measure of their conviction.
Filings activity in MDCX during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new MDCX position in Q1 2026
Institutions that fully closed their MDCX position in Q1 2026
6 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 21 | +0.0% | 86.59% | +6.47 pp | $6M | +8.1% |
| Q4 2025 | 21 | +11% | 80.12% | +17.48 pp | $6M | +28% |
| Q3 2025 | 19 | +0.0% | 62.64% | 20.26 pp | $5M | 24% |
| Q2 2025 | 19 | +171% | 82.90% | 69.04 pp | $6M | 45% |
| Q1 2025 | 7 | +75% | 151.94% | +101.68 pp | $11M | +202% |
| Q4 2024 | 4 | — | 50.26% | — | $4M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying MDCX stock.
Based on Q1 2026 13F filings, institutional ownership of Medicus Pharma Ltd. Common Stock stands at 86.6%, held across 21 reporting institutions.
Interchange Capital Partners, LLC is the largest reported institutional holder of MDCX, with approximately 1,661,871 shares worth $0.01B as of Q1 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of MDCX, including CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC.
Our composite Smart Money Score for MDCX is 65 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
7 institutions opened new positions in MDCX during Q1 2026, while 7 fully exited. 1 added to existing positions and 12 trimmed.
MDCX institutional ownership rose by 6.47 percentage points quarter-over-quarter, with a net change of +0 holders.
The top 10 institutions account for 99.6% of all reported 13F value in MDCX, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Medicus Pharma Ltd. Common Stock (MDCX) Institutional Ownership